|
28.06.2022 06:40:37
|
HBM Healthcare Investments Ltd concludes 2019 share buyback programme and launches new share buyback programme
|
HBM Healthcare Investments AG
/ Key word(s): Share Buyback
Yesterday, HBM Healthcare Investments Ltd concluded the 2019 share buyback programme that started in June 2019. Under the buyback programme, no registered shares were repurchased via the second trading line on the SIX Swiss Exchange. The Board of Directors would like to maintain the possibility of repurchasing own shares in the future through a new buyback programme, depending on the development of the business, the free liquidity and the markets. Based on the resolution of the Annual General Meeting of 10 June 2022, the Company will launch a new share buyback programme for a maximum of 696000 registered shares (10% of the registered shares entered in the commercial register) for the purpose of cancellation by capital reduction. The buyback programme will be executed via a separate trading line on the SIX Swiss Exchange. It will start on 29 June 2022 and last until 27 June 2025 at the latest. Further information on the new share buyback programme 2022 can be found on the website https://www.hbmhealthcare.com/en/investors/information. Contact
End of Media Release |
| Language: | English |
| Company: | HBM Healthcare Investments AG |
| Bundesplatz 1 | |
| 6300 Zug | |
| Switzerland | |
| Phone: | +41438887171 |
| Fax: | +41438887172 |
| E-mail: | info@hbmhealthcare.com |
| Internet: | https://www.hbmhealthcare.com |
| ISIN: | CH0012627250 |
| Valor: | 1262725 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1384959 |
| End of News | EQS News Service |
|
|
1384959 28.06.2022
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu HBM Healthcare Investments AGmehr Nachrichten
|
18.12.24 |
Successful IPO of HBM portfolio company Sai Life Sciences on the Indian stock exchanges NSE and BSE increases NAV per HBM share by 3.2 percent (EQS Group) | |
|
18.12.24 |
Erfolgreicher Börsengang des HBM-Portfoliounternehmens Sai Life Sciences an den indischen Börsen NSE und BSE erhöht NAV pro HBM-Aktie um 3.2 Prozent (EQS Group) | |
|
16.12.24 |
Key Figures 15.12.2024 (EQS Group) | |
|
02.12.24 |
Key Figures 30.11.2024 (EQS Group) | |
|
18.11.24 |
Key Figures 15.11.2024 (EQS Group) | |
|
04.11.24 |
Key Figures 31.10.2024 (EQS Group) | |
|
21.10.24 |
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures for the first six months of the 2024/2025 financial year (EQS Group) | |
|
21.10.24 |
HBM Healthcare Investments publiziert Halbjahresbericht per 30. September 2024 mit Kennzahlen für die ersten sechs Monate des Geschäftsjahrs 2024/2025 (EQS Group) |
Analysen zu HBM Healthcare Investments AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.